ABK Biomedical announces the appointment of Dr. Aravind Arepally to the newly created full-time position of Chief Medical Officer effective, September 12th, 2022.

Aravind joins ABK with extensive clinical experience in Interventional Oncology, Y90 procedures, and the medical device industry. Aravind obtained his medical degree and completed his radiology residency at Emory University in Atlanta. After finishing his fellowship at Johns Hopkins Medical Institutes, he joined the faculty, becoming an Associate Professor of Radiology and Surgery. Aravind eventually moved back to Atlanta as a practicing physician in private practice, becoming the Chair of Radiology, Section Chief of IR, and a member of the Board of Directors at Radiology Associates of Atlanta at Piedmont Hospital. He is also currently an Adjunct Professor of Radiology at Vanderbilt University School of Medicine.

In the area of medical technology development, Aravind co-founded Surefire Medical in 2010 where he was Chief Scientific Officer and spent 10 years guiding pre-clinical research, global clinical trials/strategy, and FDA interactions. Surefire (now TriSalus Life Sciences) is now commercially available in US, Europe, Asia, and South America. Additional prior industry experience includes time as a Visiting Clinical Scientist with Siemen’s Healthcare focusing on molecular imaging and image guided therapies. Most recently, Aravind left full-time clinical practice and was appointed Senior Director of R&D for Varian, Siemens Healthineers.

Aravind has received numerous NIH Grants and completed several human clinical trials in the areas of Imaging, Medical Devices, and embolotherapies. He is an author on over 150 publications, numerous medical textbooks, and has been part of faculty and lectures at over 100 conferences in his career. He has extensive teaching and mentoring experience and has consulted for many companies in the Interventional Radiology and Oncology space. He is a widely respected Key Opinion Leader in Interventional Medicine and has performed over 500 Yttrium 90 procedures in his career. His unique combination of industry, start-up, imaging, radiology, and oncology experience make him uniquely suited as the Chief Medical Officer at ABK Biomedical Inc.